24. March 2021 | Corporate News

Marinomed Biotech AG enrolls first patient in clinical study of inhaled Carragelose to treat COVID-19 infections

Press release

The full press release is available as download here:

Marinomed Biotech AG enrolls first patient in clinical study of inhaled Carragelose to treat COVID-19 infections
(132 KB)